Impact of ivabradine in decompensated heart failure due to cancer therapy‐related cardiac dysfunction

In cases of decompensated heart failure related to cancer therapy‐related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorable hemodynamics. Assessment of the overlap between the E‐ and A‐waves facilitates un...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakano, Yusuke, Ando, Hirohiko, Suzuki, Wataru, Ohashi, Hirofumi, Suzuki, Yasushi, Takashima, Hiroaki, Amano, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136441/
https://www.ncbi.nlm.nih.gov/pubmed/34026170
http://dx.doi.org/10.1002/ccr3.4133
_version_ 1783695444919975936
author Nakano, Yusuke
Ando, Hirohiko
Suzuki, Wataru
Ohashi, Hirofumi
Suzuki, Yasushi
Takashima, Hiroaki
Amano, Tetsuya
author_facet Nakano, Yusuke
Ando, Hirohiko
Suzuki, Wataru
Ohashi, Hirofumi
Suzuki, Yasushi
Takashima, Hiroaki
Amano, Tetsuya
author_sort Nakano, Yusuke
collection PubMed
description In cases of decompensated heart failure related to cancer therapy‐related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorable hemodynamics. Assessment of the overlap between the E‐ and A‐waves facilitates understanding the effects of ivabradine in such cases.
format Online
Article
Text
id pubmed-8136441
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81364412021-05-21 Impact of ivabradine in decompensated heart failure due to cancer therapy‐related cardiac dysfunction Nakano, Yusuke Ando, Hirohiko Suzuki, Wataru Ohashi, Hirofumi Suzuki, Yasushi Takashima, Hiroaki Amano, Tetsuya Clin Case Rep Case Reports In cases of decompensated heart failure related to cancer therapy‐related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorable hemodynamics. Assessment of the overlap between the E‐ and A‐waves facilitates understanding the effects of ivabradine in such cases. John Wiley and Sons Inc. 2021-05-05 /pmc/articles/PMC8136441/ /pubmed/34026170 http://dx.doi.org/10.1002/ccr3.4133 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Nakano, Yusuke
Ando, Hirohiko
Suzuki, Wataru
Ohashi, Hirofumi
Suzuki, Yasushi
Takashima, Hiroaki
Amano, Tetsuya
Impact of ivabradine in decompensated heart failure due to cancer therapy‐related cardiac dysfunction
title Impact of ivabradine in decompensated heart failure due to cancer therapy‐related cardiac dysfunction
title_full Impact of ivabradine in decompensated heart failure due to cancer therapy‐related cardiac dysfunction
title_fullStr Impact of ivabradine in decompensated heart failure due to cancer therapy‐related cardiac dysfunction
title_full_unstemmed Impact of ivabradine in decompensated heart failure due to cancer therapy‐related cardiac dysfunction
title_short Impact of ivabradine in decompensated heart failure due to cancer therapy‐related cardiac dysfunction
title_sort impact of ivabradine in decompensated heart failure due to cancer therapy‐related cardiac dysfunction
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136441/
https://www.ncbi.nlm.nih.gov/pubmed/34026170
http://dx.doi.org/10.1002/ccr3.4133
work_keys_str_mv AT nakanoyusuke impactofivabradineindecompensatedheartfailureduetocancertherapyrelatedcardiacdysfunction
AT andohirohiko impactofivabradineindecompensatedheartfailureduetocancertherapyrelatedcardiacdysfunction
AT suzukiwataru impactofivabradineindecompensatedheartfailureduetocancertherapyrelatedcardiacdysfunction
AT ohashihirofumi impactofivabradineindecompensatedheartfailureduetocancertherapyrelatedcardiacdysfunction
AT suzukiyasushi impactofivabradineindecompensatedheartfailureduetocancertherapyrelatedcardiacdysfunction
AT takashimahiroaki impactofivabradineindecompensatedheartfailureduetocancertherapyrelatedcardiacdysfunction
AT amanotetsuya impactofivabradineindecompensatedheartfailureduetocancertherapyrelatedcardiacdysfunction

Ejemplares similares